ArticleDiscover oncology2025
Causal relationship among immune cells, basal cell carcinoma, and gut microbiome: a two-sample Mendelian randomization analysis and mediation analysis.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundResearch studies suggest that the host immune system is modulated by gut microbiota (GM), which is crucial for the occurrence and progression of malignancies. Here, immune cell traits (ICTs) as mediating factors in the causative association between basal cell cancer (BCC) and gut microbiome were investigated.
methodsA two-sample Mendelian randomization (MR) analysis was undertaken to assess the influence of 412 GMs on BCC using data from a genome-wide association study (GWAS) of individuals with European ancestry. Afterward, the ICTs' mediation effect on the relationships between BCC and GM was examined using MR.
resultsInverse variance weighted method identified 9 genera and 47 ICTs that were genetically associated with BCC. Moreover, the MR demonstrated that CD33-HLA DR-AC (- 0.015, 95% CI - 0.144, 0.115) mediated a portion of the causative function of p_Firmicutes.c_Clostridia on BCC, it represented - 8.92% of the total effect.
conclusionThe current research elucidated the causal association between BCC risk, GM, and certain ICTs. This also explained the mechanism and offered potential BCC therapeutic options and preventive targets against the disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.